Corrigendum to "Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles" [Int. J. Pharm. 319 (2006) 139-146] (DOI:10.1016/j.ijpharm.2006.03.034);Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles

International Journal of Pharmaceutics

Volumn 319, Issue 1-2, 2006, Pages 139-146

  Föger, Florian ^a   Noonpakdee, Wilai ^b   Loretz, Brigitta ^a   Joojuntr, Songwut ^b   Salvenmoser, Willi ^a   Thaler, Marlene ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antisense; Chitosan nanoparticles; Malaria; Nanotechnology; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; CHITOSAN; DNA TOPOISOMERASE (ATP HYDROLYSING); NANOPARTICLE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANTIMALARIAL ACTIVITY; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DEGRADATION; DRUG RESISTANCE; ENZYME DEGRADATION; ENZYME INHIBITION; GENE SILENCING; GROWTH INHIBITION; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SURFACE CHARGE; ZETA POTENTIAL;

EID: 33745875927     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.09.049     Document Type: Erratum

References (29)

1. Baird K.J. Effectiveness of antimalarial drugs. N. Engl. J. Med. 135 (2005) 1565-1577
2. Barker R.H., Metelev V., Coakley A., and Zamecnik P. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro. Exp. Parasit. 88 (1998) 51-59
3. Carreno-Gomez B., and Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int. J. Pharm. 148 (1997) 231-240
4. Chen X., Dudgeon N., Shen L., and Wang J.H. Chemical modification of gene silencing oligonucleotides for drug discovery and development. Drug Discov. Today 10 (2005) 587-593
5. Dalton J.P., Hudson D., Adams J.H., and Miller L.H. Blocking of the receptor-mediated invasion of erythrocytes by Plasmodium knowlesi malaria with sulphated polysaccharides and glycosaminoglycans. Eur. J. Biochem. 195 (1991) 789-794
6. De Smidt P.C., Le Doan T., de Falco S., and van Berkel T.J.C. Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucl. Acids Res. 19 (1991) 4695-4700
7. Fattal E., et al. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J. Control. Rel. 53 (1998) 137-143
8. Felix C.A. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med. Pediatr. Oncol. 36 (2001) 525-535
9. Filion M.C., and Phillips N.C. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim. Biophys. Acta 1329 (1997) 345-356
10. Go M.L., Liu M., Wilairat P., Rosenthal J., Saliba K.J., and Kirk K. Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium falciparum-infected erythrocytes. Antimicrob. Agents Chemother. 48 (2004) 3241-3245
11. Goodyer I.D., et al. Characterization of macromolecular transport pathways in malaria-infected erythrocytes. Mol. Biochem. Parasit. 87 (1997) 13-28
12. Guggi D., et al. Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate. Int. J. Pharm. 278 (2004) 353-360
13. Haldar K., and Uyetake L. The movement of fluorescent endocytic tracers in Plasmodium falciparum infected erythrocytes. Mol. Biochem. Parasitol. 50 (1992) 161-177
14. Huang M., Khor E., and Lim L.Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm. Res. 21 (2004) 344-353
15. Junghans M., Kreuter J., and Zimmer A. Antisense delivery using protamine-oligonucleotide particles. Nucl. Acids Res. 28 (2000) E45
16. Kanagaratnam R., Misiura K., Rebowski G., and Ramasamy R. Malaria merozoite surface protein antisense oligodeoxynucleotides lack antisense activity but function as polyanions to inhibit red cell invasion. Int. J. Biochem. Cell Biol. 30 (1998) 979-985
17. Köping-Höggard M., et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 11 (2004) 1441-1452
18. ® loaded with oligonucleotides on cell viability and PKCα neosynthesis in HepG2 cells. Biochimie 80 (1998) 969-976
19. Lambert G., Fattal E., and Couvreur P. Nanoparticulate systems for the delivery of antisense oligonucleotides. Adv. Drug Deliv. Rev. 47 (2001) 99-112
20. Lambros C., and Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocyte stages in culture. J. Parasitol. 65 (1979) 418-420
21. Mao H.Q., et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Rel. 70 (2000) 399-421
22. Noonpakdee W., Pothikasikorn J., Nimitsantiwog W., and Wilairat P. Inhibition of Plasmodium falciparum proliferation in vitro by antisense oligodeoxynucleotides against malarial topoisomerase II. Biochem. Biophys. Res. Commun. 302 (2003) 659-664
23. Pouvelle B. Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature 353 (1991) 73-75
24. Pouvelle B., Gormley J.A., and Taraschi T.F. Characterization of trafficking pathways and membrane genesis in malaria-infected erythrocytes. Mol. Biochem. Parasitol. 66 (1994) 83-96
25. Rapaport E., Misiura K., Agrawal S., and Zamecnik P. Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum. Proc. Natl. Acad. Sci. 89 (1992) 8577-8580
26. Shaw J.P., et al. Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucl. Acids Res. 19 (1991) 747-750
27. Trager W., and Jensen J.B. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
28. Tsai Y.L., et al. Disruption of Plasmodium falciparum chitinase markedly impairs parasite invasion of mosquito midgut. Infect. Immun. 69 (2001) 4048-4054
29. Wanidworanun C., Nagel R.L., and Shear H.L. Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum. Mol. Biochem. Parasit. 102 (1999) 91-101